SUPPRESSION OF KIDNEY ALLOGRAFT REJECTION ACROSS FULL MHC BARRIERS BY RECIPIENT‐SPECIFIC ANTIBODIES TO CLASS II MHC ANTIGENS1

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Transplantation

• Publication date

  1992-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00007890-199205000-00011PMID 1585464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

  1990cited by this paper
• The molecular basis of alloreactivity.

  1990cited by this paper
• Migration and maturation of Langerhans cells in skin transplants and explants

  1990cited by this paper
• Antigen Processing for Presentation to T Lymphocytes: Function, Mechanisms, and Implications for the T‐Cell Repertoire

  1988cited by this paper
• Bulk purification of a naturally occurring soluble form of RT1-A class I major histocompatibility complex antigens from DA rat liver, and studies of specific immunosuppression.

  1987cited by this paper
• Structure of the human class I histocompatibility antigen, HLA-A2

  1987cited by this paper
• Presentation of alloantigens by host cells

  1986cited by this paper
• Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets.

  1986cited by this paper
• THE EFFECTS OF CYCLOSPORINE ON THE INDUCTION OF DONOR CLASS I AND CLASS II MHC ANTIGENS IN HEART AND KIDNEY ALLOGRAFTS IN THE RAT

  1986cited by this paper
• Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells.

  1986cited by this paper
• Functions of Purified L3T4+ and Lyt‐2+ Cells in vitro and in vivo

  1986cited by this paper
• In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products.

  1985cited by this paper
• Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients.

  1985cited by this paper
• T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.

  1984cited by this paper
• High determinant density may explain the phenomenon of alloreactivity.

  1984cited by this paper
• In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor.

  1983cited by this paper
• Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies

  1983cited by this paper
• Treatment with Anti-Ia and Antiblast/Monocyte Monoclonal Antibodies Can Prolong Skin Allograft Survival in Nonhuman Primates

  1982cited by this paper
• Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus

  1982cited by this paper
• Role of syngeneic Ia+ accessory cells in the generation of allospecific CTL responses.

  1982cited by this paper
• Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies

  1982cited by this paper
• Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells

  1982cited by this paper
• Cellular interactions in the generation of cytolytic T lymphocyte responses Analysis of the helper T cell pathway

  1981cited by this paper
• Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain

  1981cited by this paper
• In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A

  1981cited by this paper
• Passive enhancement of rat renal allografts using mouse monoclonal xenoantibodies.

  1981cited by this paper
• Human thy-1: unusual localization and possible functional significance in lymphoid tissues.

  1981cited by this paper
• Two subsets of rat T lymphocytes defined with monoclonal antibodies

  1980cited by this paper
• GRAFT ADAPTATION: STUDIES ON POSSIBLE MECHANISMS IN LONG‐TERM SURVIVING RAT RENAL ALLOGRAFTS

  1980cited by this paper
• In situ effector mechanisms in rat kidney allograft rejection. I. Characterization of the host cellular infiltrate in rejecting allograft parenchyma.

  1979cited by this paper
• Identification and unusual tissue distribution of the canine and human homologues of Thy-1 (theta)

  1979cited by this paper
• A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

  1978cited by this paper
• Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes.

  1977cited by this paper
• Antigens on mouse and rat lymphocytes recognized by rabbit antiserum against rat brain: The quantitative analysis of a xenogeneic antiserum

  1975cited by this paper
• EXPERIENCE WITH PASSIVE ENHANCEMENT OF RENAL ALLOGRAFTS IN A (DA x LEWIS)F1 TO LEWIS STRAIN COMBINATION

  1972cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Rejection of Renal Allografts: Specific Immunologic Suppression

  1968cited by this paper
• AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINS

  1968cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• CD4 T cell allorecognition pathways in acute and chronic allograft rejection

  2015cites this paper
• Functional and genetic analyses of the MHC and its impact on autoimmunity in the rat

  2013cites this paper
• Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.

  2012cites this paper
• Treatment with Anti‐MHC‐Class‐II Antibody Postpones Kidney Allograft Rejection in Primates but Increases the Risk of CMV Activation

  2004cites this paper
• INHIBITION OF THE ALLOGRAFT RESPONSE BY DONOR SPECIFIC BLOOD TRANSFUSION: ASSOCIATION WITH REDUCED LOCAL TH1 CYTOKINES AND NITRIC OXIDE BUT ENHANCED PROSTAGLANDIN E 2 PRODUCTION1

  2000cites this paper
• Xenoreactions and their modulation with bone marrow transplantation to induce tolerance

  1999cites this paper
• Modulation of alloimmunity with class I MHC peptides: mechanisms of action.

  1999cites this paper
• Induction of immunologic tolerance for transplantation.

  1999cites this paper
• Anti-major histocompatibility complex class II treatment prevents graft rejection in the hamster-to-rat cardiac xenograft.

  1999cites this paper
• Injection of mitomycin-C-treated spleen cells induces donor-specific unresponsiveness to cardiac allografts in rats.

  1999cites this paper
• A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.

  1998cites this paper
• Barrier Skin Allograft Survival Across a MHC Class II A Synthetic CD 4-CDR 3 Peptide Analog Enhances

  1998cites this paper
• Prolongation of murine vascularized heart allograft survival by recipient-specific anti-major histocompatibility complex class II antibody.

  1997cites this paper
• 6 – Immunoregulation: The Search for the Holy Grail

  1997cites this paper
• Detection of donor-specific hyporesponsiveness following late failure of human renal allografts.

  1996cites this paper
• The pharmacology of immunosuppressant drugs in skin transplant rejection in mice and other rodents.

  1995cites this paper
• T-cell recognition of an allogeneic RT1-Dbu class II MHC peptide.

  1994cites this paper
• Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin.

  1994cites this paper
• The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.

  1993cites this paper
• The kidney and primary hypertension: contributions from renal transplantation studies in animals and humans.

  1993cites this paper
• Organ acceptance and rejection.

  1992cites this paper
• The T-cell requirements for allograft rejection*

  1992cites this paper
• Cellular mechanisms of rejection.

  1992cites this paper